C-terminal fragment (Tyr-hGH 177-191) of human growth hormone. Specifically investigated for lipolytic receptor binding kinetics independent of IGF-1 somatotrophic pathways. Synthesized under strict cGMP protocols. Validated with high-performance liquid chromatography (HPLC) and electrospray ionization mass spectrometry (ESI-MS). For laboratory research use only.
Scan vial QR or input synthesis lot number.
Lipolytic Peptide
C-terminal fragment (Tyr-hGH 177-191) of human growth hormone. Specifically investigated for lipolytic receptor binding kinetics independent of IGF-1 somatotrophic pathways. Synthesized under strict cGMP protocols. Validated with high-performance liquid chromatography (HPLC) and electrospray ionization mass spectrometry (ESI-MS). For laboratory research use only.
LifeNootropics enforces rigorous multi-stage HPLC and MS analytical standards across all synthesized batches. Providing verifiable fidelity to scientific institutions worldwide.
For in-vitro research use only. Not for human consumption.